Teresa Fowler, MD
Ophthalmology · West Columbia, SCNPI 1497301873
Payments from drug & device makers
Across 51 payments — averaging $99.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$3K
- Alcon$842
- Genentech USA, Inc.$300
- Oyster Point Pharma, Inc.$250
- Glaukos Corporation$177
- AbbVie$167
- plus $633 from 10 others
What the payments were for
- Travel & lodging$2,02240%
- Food & beverage$2,93858%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 20 | $2,691 |
| Alcon | 8 | $842 |
| Genentech USA, Inc. | 3 | $300 |
| Oyster Point Pharma, Inc. | 2 | $250 |
| Glaukos Corporation | 2 | $177 |
| AbbVie(2 entities) | 4 | $167 |
| Apellis Pharmaceuticals, Inc. | 2 | $124 |
| Dompe US, Inc. | 1 | $122 |
| Sight Sciences, Inc. | 1 | $113 |
| Genentech, Inc. | 1 | $105 |
| Carl Zeiss Meditec Cataract Technology Inc. | 2 | $54 |
| Sandoz | 1 | $32 |
| Alimera Sciences, Inc. | 1 | $24 |
| Microvention, Inc. | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELLARIS ELITE$2,091
- Crystalens Accommodating IOL (AT-52AO)$2,091
- enVista MX60 IOL$2,091
- Trulign IOL$2,091
- Akreos AO IOL$2,091
- Clareon$396
- VABYSMO$272
- TYRVAYA$250
- Hydrus Microstent$139
- Centurion$135
- Oxervate$122
- AcrySof IQ VIVITY IOL$120
- OMNI(R) SURGICAL SYSTEM (US)$113
- SION SURGICAL INSTRUMENT$113
- Syfovre$109
- SUSVIMO$105
How this compares
$5,059 in reported general payments places this provider in the 70th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RocklatanNetarsudil Mesylat/Latanoprost | 11 | $12,202 |
| Latanoprost | 124 | $1,377 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 31 | $986 |
| Dorzolamide Hcl | 20 | $460 |
| Timolol Maleate | 17 | $367 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in West Columbia
- John WellsWest Columbia$7.1M
- William ClarkWest Columbia$6.2M
- John PayneWest Columbia$574K
- Daniel AlfaroCharleston$4.6M
- Kerry SolomonMt Pleasant$4.6M
- Eric JablonCharleston$1.2M
- George WaringMt Pleasant$1M
- John KerrisonCharleston$975K
- Karolinne RochaCharleston$799K
- Mona CamacciCharleston$534K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.